Skip to main content

Table 1 Inclusion and exclusion criteria for study

From: The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures

 

First Presentation

First Relapse

Second Relapse

Inclusion Criteria

Age

1 to ≤17.5 years

1 to ≤17.5 years

1 to ≤17.5 years

Proteinuria

>  3+ on dipstick; >  3 g/L on urinalysis; urine protein to creatinine ratio > 200 mg/mmol, for 3 consecutive days

>  3+ on dipstick; >  3 g/L on urinalysis; urine protein to creatinine ratio > 200 mg/mmol, for 3 consecutive days

>  3+ on dipstick; >  3 g/L on urinalysis; urine protein to creatinine ratio > 200 mg/mmol, for 3 consecutive days

Serum Albumin

<  25 g/L

<  25 g/L

<  25 g/L

Exposure to Glucocorticoids

No prior exposure to glucocorticoids

Could have prior exposure to glucocorticoids (at First Presentation)

Could have prior exposure to glucocorticoids (at First and Second Presentation)

Glucocorticoid sparing agents used

None

None

None

Exclusion Criteria

A primary disease associated with nephrotic syndrome (e.g. lupus, malignancy)

Serum C3 concentration low; suggesting alternative cause of nephrotic syndrome

Patients ultimately shown to be glucocorticoid resistant will be excluded from the final analysis (but will continue to be followed)